Digitalis associated mortality in patients after a myocardial infarction: moral responsibilities in recommending clinical trials
- 30 November 1990
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 29 (2) , 105-107
- https://doi.org/10.1016/0167-5273(90)90211-m
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinical judgement and therapeutic decision makingJournal of the American College of Cardiology, 1990
- Digoxin after Myocardial InfarctionDrugs, 1989
- Digitalis: Dead or Alive?Cardiology, 1988
- The mortality risk associated with digitalis treatment after myocardial infarctionCardiovascular Drugs and Therapy, 1987
- Digoxin Therapy and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1986
- Association of digitalis therapy with mortality in survivors of acute myocardial infarction: Observations in the beta-blocker heart attack trialJournal of the American College of Cardiology, 1985
- Effect of digitalis treatment on survival after acute myocardial infarctionThe American Journal of Cardiology, 1985
- Prognostic Importance of Digitalis After Acute Myocardial InfarctionJournal of the American College of Cardiology, 1984
- The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS).Circulation, 1983
- Digitalis-associated cardiac mortality after myocardial infarction.Circulation, 1981